Author: s.schumacher

First-author, Max C. Petersen, MD, and collaborators (Lauren Begnel, RDN, LD; Michael Wallendorf, PhD; and Marina Litivin, MD) had their article, “Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis,” published in the Journal of Cystic Fibrosis. The combination cystic fibrosis transmembrane regulator (CFTR) modulator therapy elexacaftor-tezacaftor-ivacaftor was approved by the FDA […]

A warm welcome to our 2022 clinical fellows who will join us in July, 2022. We are so pleased to have them. Alyssa Carvalho, MDNortheast Ohio Medical UniversityCleveland Clinic Akron General Kai Jones, MDWashington University School of Medicine Barnes-Jewish Hospital Doriann Klaassen, MDUniversity of Puerto Rico School of MedicineWashington University in St. LouisBarnes-Jewish Hospital Sister […]

Xuntian Jiang, assistant professor of medicine at the School of Medicine, received a five-year $2 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) for research titled “Extramural research programs in the neurosciences and neurological disorders.”

Marina Litvin, MD was recently featured on Healio.com about her presentation at the North American Cystic Fibrosis Conference 2021. Dr. Litvin discussed the “changing parameters” in nutritional status of patients with cystic fibrosis and the emergence of overnutrition and obesity, as well as the effects of highly effective modulator therapy on cardiovascular parameters. “In addition […]

First-author, Natalia Genere, MD and co-authors had the findings of their cross-sectional study published in “The Journal of Clinical Endocrinology & Metabolism” on October 14. The publication is titled, “Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.” Dexamethasone suppression test (DST) is a standard of care endocrine test […]

Washington University and BJC Healthcare have been named a Center of Excellence by the National Organization for Rare Disorders (NORD). NORD has established a national network dedicated to improving treatment and care for people with rare diseases. The program is being led by NORD to promote outstanding treatment for rare disease patients regardless of disease or geography, elevate collaboration, improve standards of […]

First author, Natalia Genere, MD and co-authors had their article, “Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study” published in the November issue of Mayo Clinic Proceedings. The authors examined the trends in incidence of clinically relevant thyroid cancers within the overall rising incidence of thyroid cancers. The […]

Julie M. Silverstein, MD and Alexandra Martirossian, MD had their article titled, “Diagnosis and Management of Growth Hormone Deficiency in Adults” published online at Consultant360. The authors discuss the physiology and causes of growth hormone deficiency (GHD), a clinical syndrome caused by decreased production of or decreased tissue responsiveness to growth hormone. According to the […]